Summary
- Current Price
- As of today, IONS price is $27.22, down -0.62% on
- Current Price All-Time High
- IONS price is currently -68.62% below its historical high of $86.74 set on
- Market Cap
- IONS current market cap is $5B, down -61.98% year-over-year
- Revenue
- IONS current annual revenue is $943.71M, up +33.83% year-over-year
- Next Earnings
- The next earnings release for IONS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Ionis Pharmaceuticals, Inc. |
| Ticker | NASDAQ: IONS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ionis.com |
| Employees | 1,069 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $27.22 | |
| Price, 1D Change | -0.62% | |
| Market Cap | $5B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.37 | |
| Revenue | $943.71M | |
| Revenue, 1Y Change | +33.83% | |
| EPS | -$2.38 | |
| EPS, 1Y Change | +21.49% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | ISIS | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$2.38 | |
| EPS Estimate | -$2.48 | |
| EPS Est. Change | -4.25% | |
| Revenue | $943.71M | |
| Revenue Estimate | $917.29M | |
| Revenue Est. Change | -2.80% | |
| Current Price | $27.22 | |
| Price Target | $70.00 | - |
| Price Tgt. Change | +157.16% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.54 | -$3.04 | -19.31% | |
| -$1.66 | -$2.38 | -43.17% | |
| -$2.48 | N/A | -4.25% | |
| -$1.75 | N/A | +26.66% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $620.13M | $705.14M | +13.71% | |
| $897.47M | $943.71M | +5.15% | |
| $917.29M | N/A | -2.80% | |
| $1.22B | N/A | +28.80% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -63.22% | |
| Price, 3Y | -44.41% | |
| Market Cap, 1Y | -61.98% | |
| Market Cap, 3Y | -35.44% | |
| Revenue, 1Y | +33.83% | |
| Revenue, 3Y | +60.67% | |
| EPS, 1Y | +21.49% | |
| EPS, 3Y | -25.35% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $27.22 | |
| SMA 200 | $63.37 | |
| SMA 50 | $41.32 | |
| EMA 200 | $56.29 | |
| EMA 50 | $41.15 | |
| MACD | -$4.81 | |
| Beta | 0.37 | |
| ATR | $2.13 | |
| 14-Day RSI | 23.26 | |
| 10-Day Volatility | 121.06% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $943.71M | |
| EPS | -$2.38 | |
| Gross Profit | $928.00M | |
| Gross Margin | 98.31% | |
| Operating Income | -$382.00M | |
| Operating Margin | -40.47% | |
| Net Income | -$381.39M | |
| Net Margin | -40.36% | |
| EBITDA | -$358.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 5.24 | |
| 1.95 | ||
| 1.94 | ||
| - | ||
| 2 | ||
| 0.26 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 4.72 | ||
| 11.52 | ||
| -9.01 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $489.09M | |
| $2.68B | ||
| $3.52B | ||
| $2.99B | ||
| $3.03B | ||
| $1.53B | ||
| Total Debt | $2.61B | |
| $1.18B | ||
| $28.08M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.33B | ||
| $1.31B | ||
| $28.36M | ||
| $0.00 | ||
| $22.69M | ||
| $0.00 | ||
| $1.79M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$268.58M | ||
| -$277.78M | ||
| $675.84M | ||
| Capex | $57.08M | |
| -$325.67M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| Oppenheimer | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| Goldman Sachs | → | |
| Needham | → | |
| BMO Capital | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
No data
Screeners with IONS
FAQ
- What is the ticker symbol for Ionis Pharmaceuticals, Inc.?
- The ticker symbol for Ionis Pharmaceuticals, Inc. is NASDAQ:IONS
- Does Ionis Pharmaceuticals, Inc. pay dividends?
- No, Ionis Pharmaceuticals, Inc. does not pay dividends
- What sector is Ionis Pharmaceuticals, Inc. in?
- Ionis Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Ionis Pharmaceuticals, Inc. in?
- Ionis Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Ionis Pharmaceuticals, Inc. based in?
- Ionis Pharmaceuticals, Inc. is headquartered in United States
- When did Ionis Pharmaceuticals, Inc. go public?
- Ionis Pharmaceuticals, Inc. initial public offering (IPO) was on May 17, 1991
- Is Ionis Pharmaceuticals, Inc. in the S&P 500?
- No, Ionis Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Ionis Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Ionis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Ionis Pharmaceuticals, Inc. in the Dow Jones?
- No, Ionis Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Ionis Pharmaceuticals, Inc. last earnings report?
- Ionis Pharmaceuticals, Inc.'s most recent earnings report was on November 9, 2026
- When does Ionis Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Ionis Pharmaceuticals, Inc. is February 24, 2027
Data Sources & References
- IONS Official Website www.ionis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/874015/000087401526000115/0000874015-26-000115-index.htm
- IONS Profile on Yahoo Finance finance.yahoo.com/quote/IONS
- IONS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ions
